More specifically, researchers have the supposition that clofibrate suppresses the growth of breast cancer cells by repressing NF-κB and extracellular regulated protein kinases1/2 (ERK1/2) activation, inhibiting cyclinD1, cyclinA, cyclinE, and inducing pro-apoptotic P21 levels. This evidence concerns the gene NFKB1 and breast carcinoma.